<DOC>
	<DOCNO>NCT02071056</DOCNO>
	<brief_summary>The purpose study learn whether DNA cancer tumor cell find cerebral spinal fluid ( CSF ) bath brain spinal cord patient malignant cancer cell able find CSF . The researcher study hope information use develop way diagnose LM earlier .</brief_summary>
	<brief_title>Circulating Tumor DNA Cerebrospinal Fluid Early Biomarker Leptomeningeal Metastasis ( LM )</brief_title>
	<detailed_description />
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Meningeal Carcinomatosis</mesh_term>
	<criteria>1 . Patient must previously diagnose solid tumor malignancy originate visceral organ ( i.e. , outside CNS ) , present sign and/or symptom consistent carcinomatous meningitis ( headache , vision dysfunction , hear loss , cranial nerve deficit , cognitive dysfunction , focal weakness numbness suggestive cranial neuropathy radiculopathy , cauda equine syndrome , meningismus , and/or bowel bladder dysfunction ) . 2 . Age ≥ 18 year . 3 . Patients meet accept standard care follow FDA guidance low molecular weight heparin use prior lumbar puncture , specifically INR &lt; 1.4 PT within normal range DHMC laboratory , platelet count &gt; 50,000 . For enoxaparin use , delay Lumbar puncture allow least 12 hour administration prophylactic dos , use prevention deep vein thrombosis . Longer delay ( 24 hour ) appropriate consider patient receive higher therapeutic dos enoxaparin ( 1 mg/kg twice daily 1.5 mg/kg daily ) . A postprocedure dose enoxaparin usually give sooner 4 hour lumbar puncture . Aspirin antiplatelet therapy permit without timing constraint prior lumbar puncture . 4 . Patient must consent provide additional CSF ( 10 mL ) blood ( 10 mL ) fluid draw part clinically indicated procedure . 5 . Patient must consent permit genetic analysis cancer . 6 . Patient capable give informed consent . 7 . MRI clinically symptomatic area ( spine and/or brain ) and/or head CT within last 3 month exclude brain disease would contraindicate lumbar puncture . 1 . Evidence CNS mass create mass‐effect midline shift lumbar puncture contraindicate . 2 . Previous current hematological malignancy . 3 . Previous current primary CNS malignancy . 4 . Prior treatment CNS metastasis . 5 . Known CNS autoimmune inflammatory disease ( i.e. , Multiple Sclerosis , neurosarcoidosis , chronic fungal , rickettsial bacterial meningitis ) . 6 . Patient currently receive treatment LM . 7 . Patient previously diagnose LM .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>